- Home
- RERE vs CLPT Comparison
RERE vs CLPT Comparison
Compare RERE & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RERE
- CLPT
- Stock Information
- Founded
- RERE 2011
- CLPT 1998
- Country
- RERE China
- CLPT United States
- Employees
- RERE N/A
- CLPT N/A
- Industry
- RERE Other Specialty Stores
- CLPT Medical/Dental Instruments
- Sector
- RERE Consumer Discretionary
- CLPT Health Care
- Exchange
- RERE Nasdaq
- CLPT Nasdaq
- Market Cap
- RERE 444.1M
- CLPT 376.2M
- IPO Year
- RERE 2021
- CLPT N/A
- Fundamental
- Price
- RERE $2.90
- CLPT $11.27
- Analyst Decision
- RERE
- CLPT Strong Buy
- Analyst Count
- RERE 0
- CLPT 3
- Target Price
- RERE N/A
- CLPT $25.00
- AVG Volume (30 Days)
- RERE 759.2K
- CLPT 289.2K
- Earning Date
- RERE 08-19-2025
- CLPT 08-06-2025
- Dividend Yield
- RERE N/A
- CLPT N/A
- EPS Growth
- RERE N/A
- CLPT N/A
- EPS
- RERE 0.07
- CLPT N/A
- Revenue
- RERE $2,388,301,386.00
- CLPT $32,235,999.00
- Revenue This Year
- RERE $27.37
- CLPT $23.97
- Revenue Next Year
- RERE $24.06
- CLPT $27.52
- P/E Ratio
- RERE $40.03
- CLPT N/A
- Revenue Growth
- RERE 26.09
- CLPT 23.22
- 52 Week Low
- RERE $2.00
- CLPT $5.11
- 52 Week High
- RERE $3.70
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- RERE 63.02
- CLPT 38.46
- Support Level
- RERE $2.64
- CLPT $11.03
- Resistance Level
- RERE $2.89
- CLPT $14.23
- Average True Range (ATR)
- RERE 0.14
- CLPT 0.68
- MACD
- RERE 0.03
- CLPT -0.16
- Stochastic Oscillator
- RERE 73.13
- CLPT 6.25
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.